The Manufacturers Life Insurance Company reduced its stake in shares of Innospec Inc. (NASDAQ:IOSP – Free Report) by 1.6% in the third quarter, HoldingsChannel.com reports. The firm owned 13,665 shares of the specialty chemicals company’s stock after selling 227 shares during the period. The Manufacturers Life Insurance Company’s holdings in Innospec were worth $1,545,000 as of its most recent SEC filing.
A number of other hedge funds have also recently bought and sold shares of IOSP. CWM LLC lifted its position in shares of Innospec by 239.6% during the 2nd quarter. CWM LLC now owns 635 shares of the specialty chemicals company’s stock valued at $78,000 after buying an additional 448 shares during the last quarter. Blue Trust Inc. lifted its holdings in shares of Innospec by 503.9% during the 3rd quarter. Blue Trust Inc. now owns 779 shares of the specialty chemicals company’s stock worth $96,000 after acquiring an additional 650 shares during the last quarter. nVerses Capital LLC raised its stake in shares of Innospec by 200.0% during the third quarter. nVerses Capital LLC now owns 900 shares of the specialty chemicals company’s stock worth $102,000 after acquiring an additional 600 shares in the last quarter. Point72 DIFC Ltd bought a new stake in Innospec in the second quarter worth $184,000. Finally, Sanctuary Advisors LLC bought a new position in Innospec during the 2nd quarter worth approximately $233,000. 96.64% of the stock is owned by hedge funds and other institutional investors.
Innospec Stock Down 0.2 %
Shares of IOSP stock opened at $116.31 on Wednesday. Innospec Inc. has a twelve month low of $103.97 and a twelve month high of $133.71. The stock has a market cap of $2.90 billion, a price-to-earnings ratio of 20.30 and a beta of 1.09. The business’s fifty day moving average is $115.23 and its 200 day moving average is $117.64.
Innospec Increases Dividend
The firm also recently announced a Semi-Annual dividend, which was paid on Tuesday, November 26th. Shareholders of record on Monday, November 18th were given a $0.79 dividend. This is a positive change from Innospec’s previous Semi-Annual dividend of $0.72. The ex-dividend date was Monday, November 18th. This represents a yield of 1.3%. Innospec’s payout ratio is 27.57%.
Analyst Upgrades and Downgrades
Separately, StockNews.com raised Innospec from a “buy” rating to a “strong-buy” rating in a research note on Tuesday.
View Our Latest Research Report on Innospec
Insider Transactions at Innospec
In other Innospec news, Director Milton C. Blackmore sold 1,035 shares of Innospec stock in a transaction that occurred on Wednesday, November 13th. The stock was sold at an average price of $122.92, for a total value of $127,222.20. Following the sale, the director now owns 9,028 shares of the company’s stock, valued at $1,109,721.76. The trade was a 10.29 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Company insiders own 1.35% of the company’s stock.
Innospec Company Profile
Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.
Featured Articles
- Five stocks we like better than Innospec
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Survey Reveals: Which States Saw the Biggest Investment Gains in 2024?
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Amazon’s Healthcare Gamble: A New Era of Medical Disruption
- How to Read Stock Charts for Beginners
- Semiconductor Giant Synopsys Slides 14% — Time to Take Notice
Want to see what other hedge funds are holding IOSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innospec Inc. (NASDAQ:IOSP – Free Report).
Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.